Interface Biologics Inc.
logo BDC

Interface Biologics Inc.

Interface Biologics is a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.

Investment year:  2005
Industry sector:  Devices
Region:  Ontario
Website
Follow Interface Biologics Inc.

Recent news

Interface Biologics announces series B financing round with DSM and BDC Capital

Learn More
v17.9.0.10395